CONDORELLI, Gianluigi
 Distribuzione geografica
Continente #
NA - Nord America 12.231
AS - Asia 7.422
EU - Europa 2.160
SA - Sud America 1.420
AF - Africa 361
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
Totale 23.611
Nazione #
US - Stati Uniti d'America 11.987
SG - Singapore 4.644
CN - Cina 1.224
BR - Brasile 1.201
VN - Vietnam 695
FI - Finlandia 429
IE - Irlanda 345
IT - Italia 257
DE - Germania 245
NG - Nigeria 242
HK - Hong Kong 210
FR - Francia 177
GB - Regno Unito 158
IN - India 148
CA - Canada 116
SE - Svezia 112
NL - Olanda 110
AR - Argentina 89
BD - Bangladesh 78
RU - Federazione Russa 76
MX - Messico 69
IQ - Iraq 64
TR - Turchia 49
JP - Giappone 47
BE - Belgio 40
EC - Ecuador 31
PL - Polonia 30
ID - Indonesia 29
ZA - Sudafrica 29
IL - Israele 28
CZ - Repubblica Ceca 26
ES - Italia 25
PK - Pakistan 25
UA - Ucraina 25
CL - Cile 22
MA - Marocco 22
CO - Colombia 21
VE - Venezuela 21
SA - Arabia Saudita 20
PH - Filippine 16
UZ - Uzbekistan 16
JM - Giamaica 15
AE - Emirati Arabi Uniti 14
EG - Egitto 14
JO - Giordania 14
KE - Kenya 13
PY - Paraguay 13
AZ - Azerbaigian 12
DZ - Algeria 12
KR - Corea 12
MY - Malesia 11
RO - Romania 11
AT - Austria 10
GR - Grecia 10
UY - Uruguay 9
ET - Etiopia 8
PE - Perù 8
BB - Barbados 7
CR - Costa Rica 7
HN - Honduras 7
LT - Lituania 7
PT - Portogallo 7
TH - Thailandia 7
AU - Australia 6
BG - Bulgaria 6
GE - Georgia 6
BY - Bielorussia 5
CH - Svizzera 5
HR - Croazia 5
MD - Moldavia 5
NO - Norvegia 5
NP - Nepal 5
OM - Oman 5
TN - Tunisia 5
TW - Taiwan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AL - Albania 4
AM - Armenia 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
EE - Estonia 4
IR - Iran 4
KG - Kirghizistan 4
PR - Porto Rico 4
RS - Serbia 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BA - Bosnia-Erzegovina 3
BN - Brunei Darussalam 3
CG - Congo 3
CU - Cuba 3
DK - Danimarca 3
HU - Ungheria 3
KZ - Kazakistan 3
LK - Sri Lanka 3
LY - Libia 3
MN - Mongolia 3
SK - Slovacchia (Repubblica Slovacca) 3
GA - Gabon 2
KH - Cambogia 2
Totale 23.574
Città #
Singapore 2.056
Chandler 1.715
Wilmington 1.491
Ashburn 783
The Dalles 762
San Jose 632
Shanghai 566
San Mateo 553
Ann Arbor 473
Helsinki 427
New York 401
Dallas 391
Boardman 373
Dublin 342
Leawood 248
Lawrence 242
Princeton 242
Benin City 241
Ho Chi Minh City 224
Beijing 218
Hong Kong 201
Hanoi 179
Los Angeles 147
Woodbridge 133
Fairfield 127
Paris 123
Santa Clara 107
São Paulo 100
Amsterdam 90
Milan 78
Columbus 77
London 65
Seattle 65
Council Bluffs 63
Pune 62
San Diego 50
Toronto 47
Buffalo 46
Rio de Janeiro 41
Brussels 39
Falkenstein 39
Tokyo 35
Orem 32
Da Nang 31
Moscow 30
Haiphong 29
Norwalk 29
Phoenix 28
Baghdad 27
Munich 27
Chicago 26
Naples 26
Warsaw 26
Falls Church 25
Mexico City 25
Montreal 25
Brasília 24
Chennai 23
Curitiba 22
Abbiategrasso 21
Belo Horizonte 21
Brooklyn 19
Stockholm 19
Johannesburg 18
Brno 17
Campinas 17
Boston 16
Dhaka 16
Tashkent 16
San Francisco 15
Frankfurt am Main 14
Guayaquil 14
Houston 14
Porto Alegre 14
Atlanta 13
Jakarta 13
Kocaeli 13
Ribeirão Preto 13
Baku 12
Changsha 12
Charlotte 12
Fortaleza 12
Hangzhou 12
Hải Dương 12
Nairobi 12
Denver 11
Hillsboro 11
Kingston 11
Amman 10
Des Moines 10
Quito 10
Salvador 10
Biên Hòa 9
Bogotá 9
Guangzhou 9
Hortolândia 9
Manchester 9
New Delhi 9
Reston 9
Riyadh 9
Totale 15.281
Nome #
Direct oral anticoagulants in addition to antiplatelet therapy for secondary prevention after acute coronary syndromes: an updated systematic review and meta-analysis 140
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. 136
A G613A missense in the Hutchinson's progeria lamin A/C gene causes a lone, autosomal dominant atrioventricular block. 128
Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS-ONE trial 120
RNA (Epi)genetics in cardiovascular diseases 119
TGFβ triggers miR-143/145 transfer from smooth muscle cells to endothelial cells, thereby modulating vessel stabilization 118
Hypoglycemia and hyperglycemia are risk factors for falls in the hospital population 114
Endovascular treatment vs. intravenous thrombolysis alone for ischaemic stroke: a meta-analysis of randomised controlled trials 113
[Continuity of care in heart failure: pilot study of the Tuscany region]. 111
Coral Reef Aorta: A Rare Occlusive Disease of the Aorta Complicating Decision Making for Severe Aortic Stenosis Treatment. 109
MicroRNAs and cardiac pathology 107
Dual Antiplatelet Therapy Continuation Beyond 1 Year After Drug-Eluting Stents: A Meta-Analysis of Randomized Trials 107
Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: Effects on blood pressure control and mortality 107
Clinical relevance of clonal hematopoiesis in persons aged ≥80 years 107
Adeno-associated virus-mediated CASQ2 delivery rescues phenotypic alterations in a patient-specific model of recessive catecholaminergic polymorphic ventricular tachycardia 106
DNA hydroxymethylation controls cardiomyocyte gene expression in development and hypertrophy 105
miR-128-3p is a novel regulator of vascular smooth muscle cell phenotypic switch and vascular diseases 105
T cell costimulation blockade blunts pressure overload-induced heart failure 105
Akt mediates the cross-talk between beta-adrenergic and insulin receptors in neonatal cardiomyocytes 104
Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure 103
Adenovirus-mediated gene transfer of the retinoblastoma family member p130/RB2 blocks restenosis after endothelial injury 101
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19 101
Adenoviral gene transfer of Akt enhances myocardial contractility and intracellular calcium handling 99
Therapeutic use of microRNAs in myocardial diseases 98
The B subunit of the CAAT-binding factor NFY binds the central segment of the co-activator p300 98
Cardioprotection with nebivolol in patients undergoing anthracyclines: a randomized placebo-controlled trial 97
Akt regulates L-type Ca2+ channel activity by modulating Cavalpha1 protein stability 97
Defining circulating mononuclear cells in heart failure through single-cell RNA sequencing: new insights for an old disease 97
A risk score based on baseline risk factors for predicting mortality in COVID-19 patients 97
Circ_Lrp6, a Circular RNA Enriched in Vascular Smooth Muscle Cells, Acts as a Sponge Regulating miRNA-145 Function 96
Critical Organizational Issues for Cardiologists in the COVID-19 Outbreak: A Frontline Experience From Milan, Italy 96
Coronary Artery Dissection in Drug-Coated Balloon Angioplasty: Incidence, Predictors, and Clinical Outcomes 96
Epigenetics : a new mechanism of regulation of heart failure? 95
Translating cardioprotection for patient benefit : position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology 95
Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy 95
mTOR regulates brain morphogenesis by mediating GSK3 signaling. 94
Electroactive polyurethane/siloxane derived from castor oil as a versatile cardiac patch, part II: HL-1 cytocompatibility and electrical characterizations 94
Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy 94
Differential expression and functional role of GATA-2, NF-E2 and GATA-1 in normal adult erythropoiesis 93
Dietary essential amino acids for the treatment of heart failure with reduced ejection fraction 92
Opposing roles of Akt and STAT3 in protection of the maternal heart from peripartum stress 92
Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair 92
UHRF1 epigenetically orchestrates smooth muscle cell plasticity in arterial disease 92
Histone Methyltransferase G9a Is Required for Cardiomyocyte Homeostasis and Hypertrophy. 92
P2Y12 Inhibitors Monotherapy in Patients Undergoing Complex vs Non-Complex Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials 91
Dr. John Ross Jr. 91
Activation of cAMP-PKA signalling in vivo inhibits smooth muscle cell proliferation after vascular injury 91
Aerobic interval training enhances cardiomyocyte contractility and Ca2+ cycling by phosphorylation of CaMKII and Thr-17 phospholamban 90
The possible role of chromosome X variability in hypertensive familiarity. 90
Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials 90
Association of FOXO3A locus with extreme longevity in the Southern Italian Centenarian Study 89
Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice 89
MicroRNAs in cardiovascular biology and heart disease 89
Inhalation Therapy Delivers Nanoparticle-Based Therapeutic Biomolecules To The Diseased Heart 89
T Cell Costimulation Blockade Blunts Age-Related Heart Failure 89
Association Between Colchicine Treatment and Clinical Outcomes in Patients with Coronary Artery Disease: Systematic Review and Meta-analysis 88
Exercise training reverses myocardial dysfunction induced by CaMKIIδC overexpression by restoring Ca2+ homeostasis. 88
The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease 88
Mutated p21/WAF/CIP transgene overstatement reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice 88
Abnormal responses to saline load in hypertensive patients with parental history of cardiovascular accidents 88
Antiphosphotyrosine recovery of an isulin-stimulated receptor phosphatase activity in FRTL5 cells 87
Interleukin-6 Trans-Signaling and Risk of Future Cardiovascular Events: A New Avenue for Atheroprotection? 87
Electroactive polyurethane/siloxane derived from castor oil as a versatile cardiac patch, part I: Synthesis, characterization,and myoblast proliferation and differentiation 87
RBP and microRNA control of endothelial cell function 86
An autofluorescence-based method for the isolation of highly purified ventricular cardiomyocytes 86
Physiological myocardial hypertrophy: how and why? 86
A pentamer transcriptional complex including tal-1 and retinoblastoma protein downmodulates c-kit expression in normal erythroblasts 86
Single-Cell Sequencing of Mouse Heart Immune Infiltrate in Pressure Overload-Driven Heart Failure Reveals Extent of Immune Activation 86
The long noncoding RNA landscape in cardiovascular disease: a brief update. 85
p300/CBP modulates co-operation between MEF2A and TR/RxR 85
Akt increases sarcoplasmic reticulum Ca2+ cycling by direct phosphorylation of phospholamban at Thr17 85
Uses and compositions comprising mirnas 85
Genetic variants in CCNB1 associated with differential gene transcription and risk of coronary in-stent restenosis 84
Inhibition of Class I Histone Deacetylase with an Apicidine Derivative Prevents Cardiac Hypertrophy and Failure 84
A Nitric Oxide-releasing Derivative of Enalapril, NCX-899, Prevents Progressive LV Dysfunction and Improves Remodeling in Cardiomyopathic Hamsters with Heart Failure 84
Deciphering the beta-adrenergic response in human embryonic stem cell-derived-cardiac myocytes: closer to clinical use? 83
Circulating microRNAs and aerobic fitness : the HUNT-study 83
MicroRNAs as Companion Biomarkers for the Diagnosis and Prognosis of Acute Coronary Syndromes 83
MicroRNAs in cardiovascular disease: an introduction for clinicians 83
Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 patients 83
The emerging role of microRNAs in cardiovascular biology 82
Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy 82
Epigenetics in heart failure 81
Akt1 gene transfer to the endothelium corrects impaired endothelial dependent vasorelaxation in hypertensive rats 81
MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts 81
The cdc2-related kinase, PISSLRE, is essential for cell growth and acts in G2 phase of the cell cycle 80
Arterial remodeling and atherosclerosis: miRNAs involvement 80
Endoplasmic reticulum stress at the crossroads of progeria and atherosclerosis 80
ST-Elevation Myocardial Infarction in Patients with COVID-19: Clinical and Angiographic Outcomes 80
MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism 80
p130/pRb2 has a similar yet distinctive growth suppressive properties as retinoblastoma family members, pRb and p107 79
Chemerin processing in the myocardium: A mechanism in search of a function 79
MiR-133a regulates collagen 1A1: potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension 79
SOCS1 gene transfer accelerates the transition to heart failure through the inhibition of the gp130/JAK/STAT pathway 79
Characterization of Myocardial Injury in Patients With COVID-19 79
Long Noncoding RNA : a New Player of Heart Failure? 78
Reply to letter to the editor by Bonaventura et al 78
Molecular determinants of the physiological adaptation to stress in the cardiomyocyte: a focus on AKT 77
IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation 77
Evidence for oxidative activation of c-Myc-dependent nuclear signaling in human coronary SMC and in early lesions of WHHL rabbits: protective effects of vitamin E 77
Totale 9.272
Categoria #
all - tutte 156.897
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 156.897


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021262 0 0 0 0 0 0 0 0 0 0 0 262
2021/20221.209 31 20 20 316 20 18 42 201 103 91 246 101
2022/20234.490 546 116 347 553 500 398 4 419 840 395 300 72
2023/20242.523 213 246 551 147 78 358 141 149 41 63 174 362
2024/20254.234 140 89 71 96 188 482 299 504 526 924 489 426
2025/20268.736 1.386 494 386 681 306 414 2.755 487 502 557 437 331
Totale 23.851